Gene · 23765
Papers3,930
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 3,930
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Molecular Signatures of Bladder Pain Syndrome: A Systematic Review Towards Phenotype-Informed Diagnostics. | Int Urogynecol J | 2026 | 42084644 | PubTator, text mining | PubMed |
| INDIVIDUAL ARTICLE: Clinical and Real-World Implications of IL-17 Receptor Blockade in Plaque Psoriasis and Psoriatic Arthritis With Brodalumab. | J Drugs Dermatol | 2026 | 42081640 | PubTator, text mining | PubMed |
| CXCL5 is associated with neutrophil-driven intestinal inflammation and IL-17-associated epithelial signaling in inflammatory bowel disease. | Sci Rep | 2026 | 42056229 | PubTator, text mining | PubMed |
| Interleukin-17 Inhibitors and the Potential Association of Systemic Lupus Erythematosus. | Kidney Med | 2026 | 42027197 | PubTator, text mining | PubMed |
| Majoon Ushba alleviated IL-17A sensitized keratinocyte ferroptosis via JAK-2-STAT-3 signaling axis and reversed imiquimod induced psoriasiform inflammation. | Pharm Biol | 2026 | 41973793 | PubTator, text mining | PubMed |
| Senescence-like cells recruit γδ T cells to drive prolonged hyposmia after SARS-CoV-2 infection in mice. | EMBO Rep | 2026 | 41963730 | PubTator, text mining | PubMed |
| Effect of the intestinal microbiota on TH17 cell-derived cytokines in the context of intestinal inflammation. | Semin Immunopathol | 2026 | 41925908 | PubTator, text mining | PubMed |
| Obesity and Cancer: From Systemic Metabolic Reprogramming to Immunotherapy Paradox. | Metabolites | 2026 | 41893325 | PubTator, text mining | PubMed |
| Smart Hydrogel for the Treatment of Rheumatoid Arthritis. | Gels | 2026 | 41892532 | PubTator, text mining | PubMed |
| Vicenin-2 attenuates rosacea-like inflammation by inhibiting IL-17RA signaling. | Front Pharmacol | 2026 | 41883500 | PubTator, text mining | PubMed |
| Transcriptional readthrough precedes alternative splicing programs triggered in CML cells by imatinib. | Sci Adv | 2026 | 41860998 | PubTator, text mining | PubMed |
| Tissue-Based Transcriptomic Profiling of Gastrointestinal Graft Versus Host Disease Reveals Immune and MicroRNA Dysregulation. | Int J Mol Sci | 2026 | 41828729 | PubTator, text mining | PubMed |
| Beyond inflammation: alarmins as critical drivers of pulmonary fibrosis. | ERJ Open Res | 2026 | 41809871 | PubTator, text mining | PubMed |
| Emodin inhibits breast tumorigenesis in the comorbidity of hyperlipidemia and associated with IL-17 suppression. | Biochem Biophys Rep | 2026 | 41799696 | PubTator, text mining | PubMed |
| The Th17/Treg axis: a key to understanding and treating autoimmune disorders. | Open Life Sci | 2026 | 41799642 | PubTator, text mining | PubMed |
| Interaction of brain endothelial cells with T cells: implications for progression and therapeutic strategies of multiple sclerosis. | Front Neurol | 2026 | 41798818 | PubTator, text mining | PubMed |
| Exosome-delivered bioactive molecules regulate macrophage polarization in atherosclerosis and myocardial infarction: mechanisms and therapeutic potential. | Front Cardiovasc Med | 2026 | 41798608 | PubTator, text mining | PubMed |
| Microneedle-based delivery of cell membrane vesicles as IL-17RA decoys for Psoriasis treatment. | J Nanobiotechnology | 2026 | 41796358 | PubTator, text mining | PubMed |
| Methyl-CpG-binding domain protein 2 epigenetically represses monocyte HLA-DR expression and promotes immune paralysis in HBV-related acute-on-chronic liver failure. | Front Immunol | 2026 | 41789066 | PubTator, text mining | PubMed |
| Oncostatin M receptor deficiency as a novel candidate genetic cause of autosomal recessive hyper-IgE syndrome. | J Hum Immun | 2026 | 41783139 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/23765/papers?page=3